{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:14:56Z","timestamp":1790612096764,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,2,21]],"date-time":"2017-02-21T00:00:00Z","timestamp":1487635200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,2,21]],"date-time":"2017-02-21T00:00:00Z","timestamp":1487635200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5 R21 CA165093-010"],"award-info":[{"award-number":["5 R21 CA165093-010"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1007\/s10552-017-0864-4","type":"journal-article","created":{"date-parts":[[2017,2,21]],"date-time":"2017-02-21T09:11:40Z","timestamp":1487668300000},"page":"299-308","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Personalized medicine for prevention: can risk stratified screening decrease colorectal cancer mortality at an acceptable cost?"],"prefix":"10.1007","volume":"28","author":[{"given":"Sujha","family":"Subramanian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgiy","family":"Bobashev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"Hoover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,2,21]]},"reference":[{"key":"864_CR1","unstructured":"U.S. Cancer Statistics Working Group (2014) United States Cancer Statistics: 1999\u20132011 Incidence and Mortality Web-based Report. 2014 \n                    http:\/\/www.cdc.gov\/uscs"},{"key":"864_CR2","unstructured":"National Colorectal Cancer Roundtable (2015) 80% screening rate by 2018. \n                    http:\/\/nccrt.org\/tools\/80-percent-by-2018\n                    \n                  . Accessed 22 Aug 2015"},{"issue":"23","key":"864_CR3","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.1001\/jama.2016.6828","volume":"315","author":"AB Knudsen","year":"2016","unstructured":"Knudsen AB, Zauber AG, Rutter CM et al (2016) Estimation of benefits, burden, and harms of colorectal cancer screening strategies: modeling study for the US preventive services task force. JAMA 315(23):2595\u20132609. doi:\n                    10.1001\/jama.2016.68282529493","journal-title":"JAMA"},{"issue":"23","key":"864_CR4","doi-asserted-by":"publisher","first-page":"2564","DOI":"10.1001\/jama.2016.5989","volume":"315","author":"K Bibbins-Domingo","year":"2016","unstructured":"Bibbins-Domingo K, Grossman DC, Curry SJ et al (2016) Screening for colorectal cancer: us preventive services task force recommendation statement. JAMA 315(23):2564\u20132575. doi:\n                    10.1001\/jama.2016.59892529486","journal-title":"JAMA"},{"issue":"23","key":"864_CR5","doi-asserted-by":"publisher","first-page":"2576","DOI":"10.1001\/jama.2016.3332","volume":"315","author":"JS Lin","year":"2016","unstructured":"Lin JS, Piper MA, Perdue LA et al (2016) Screening for colorectal cancer: updated evidence report and systematic review for the US preventive services task force. JAMA 315(23):2576\u20132594. doi:\n                    10.1001\/jama.2016.33322529492","journal-title":"JAMA"},{"issue":"17","key":"864_CR6","first-page":"464","volume":"64","author":"S Sabatino","year":"2013","unstructured":"Sabatino S, White M, Thompson T, Klabunde C (2013) Centers for disease control and prevention (CDC). Cancer screening test use\u2014United States, 2013. MMWR 64(17):464\u2013468","journal-title":"MMWR"},{"issue":"1","key":"864_CR7","first-page":"108","volume":"15","author":"JA Fisher","year":"2006","unstructured":"Fisher JA, Fikry C, Troxel AB (2006) Cutting cost and increasing access to colorectal cancer screening: another approach to following the guidelines. CEBP 15(1):108\u2013113","journal-title":"CEBP"},{"issue":"9","key":"864_CR8","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1377\/hlthaff.2008.0898","volume":"29","author":"S Subramanian","year":"2010","unstructured":"Subramanian S, Bobashev G, Morris RJ (2010) When budgets are tight, there are better options than colonoscopies for colorectal cancer screening. Health Aff 29(9):1734\u20131740","journal-title":"Health Aff"},{"issue":"4","key":"864_CR9","doi-asserted-by":"publisher","first-page":"dju032","DOI":"10.1093\/jnci\/dju032","volume":"106","author":"S Gupta","year":"2014","unstructured":"Gupta S, Sussman DA, Doubeni CA, Anderson DS, Day L, Deshpande AR et al (2014) Challenges and possible solutions to colorectal cancer screening for the underserved. JNCI 106(4):dju032","journal-title":"JNCI"},{"key":"864_CR10","unstructured":"Genetics of Colorectal Cancer\u2013for health professionals (PDQ\u00ae). \n                    http:\/\/www.cancer.gov\/types\/colorectal\/hp\/colorectal-genetics-pdq#section\/_1\n                    \n                  . Accessed 20 June 2015"},{"issue":"11","key":"864_CR11","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1097\/GIM.0b013e3181f30e9e","volume":"12","author":"MT Scheuner","year":"2010","unstructured":"Scheuner MT, McNeel TS, Freedman AN (2010) Population prevalence of familial cancer and common hereditary cancer syndromes. The 2005 California health interview survey. Genet Med 12(11):726\u2013735","journal-title":"Genet Med"},{"issue":"8","key":"864_CR12","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1056\/NEJM199808203390804","volume":"339","author":"JT Wijnen","year":"1998","unstructured":"Wijnen JT, Vasen HF, Khan PM, Zwinderman AH, van der Klift H, Mulder A, et al (1998) Clinical findings with implications for genetic testing in families with clustering of colorectal cancer. NEJM 339(8):511\u2013518","journal-title":"NEJM"},{"issue":"5","key":"864_CR13","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1200\/JCO.2008.17.4797","volume":"27","author":"AN Freedman","year":"2009","unstructured":"Freedman AN, Slattery ML, Ballard-Barbash R, Willis G, Cann BJ, Pee D et al (2009) Colorectal cancer risk prediction tool for white men and women without known susceptibility. JCO 27(5):686\u2013693","journal-title":"JCO"},{"issue":"5","key":"864_CR14","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1200\/JCO.2008.17.4813","volume":"27","author":"Y Park","year":"2009","unstructured":"Park Y, Freedman AN, Gail MH, Willis G, Cann BJ, Pee D et al (2009) Validation of a colorectal cancer risk prediction model among white patients age 50 years and older. JCO 27(5):694\u2013698","journal-title":"JCO"},{"issue":"10","key":"864_CR15","first-page":"e1621","volume":"1624\u20131634","author":"GK Ma","year":"2014","unstructured":"Ma GK, Ladabaum U (2014) Personalizing colorectal cancer screening: a systematic review of models to predict risk of colorectal neoplasia. Clin Gastroenterol Hepatol 1624\u20131634(10):e1621","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"864_CR16","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3122\/jabfm.2014.01.130040","volume":"27","author":"BJ Wells","year":"2014","unstructured":"Wells BJ, Kattan MW, Cooper GS, Jackson L, Koroukian S (2014) Colorectal cancer predicted risk online (CRC-PRO) calculator using data from the multi-ethnic cohort study. JABFM 27(1):42\u201355","journal-title":"JABFM"},{"issue":"6","key":"864_CR17","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1038\/ajg.2011.20","volume":"106","author":"BE Levitzky","year":"2011","unstructured":"Levitzky BE, Brown CC, Heeren TC, Schroy PC 3rd (2011) Performance of a risk index for advanced proximal colorectal neoplasia among a racially\/ethnically diverse patient population. Am J Gastroenterol 106(6):1099\u20131106","journal-title":"Am J Gastroenterol"},{"issue":"15","key":"864_CR18","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1001\/jama.284.15.1954","volume":"284","author":"AL Frazier","year":"2000","unstructured":"Frazier AL, Colditz GA, Fuchs CS, Kuntz KM (2000) Cost-effectiveness of screening for colorectal cancer in the general population. JAMA 284(15):1954\u20131961","journal-title":"JAMA"},{"issue":"4","key":"864_CR19","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1053\/j.gastro.2005.07.059","volume":"129","author":"U Ladabaum","year":"2005","unstructured":"Ladabaum U, Song K (2005) Projected national impact of colorectal cancer screening on clinical and economic outcomes and health services demand. Gastroenterology 129(4):1151\u20131162","journal-title":"Gastroenterology"},{"issue":"7","key":"864_CR20","first-page":"1971","volume":"18","author":"S Subramanian","year":"2009","unstructured":"Subramanian S, Bobashev G, Morris RJ (2009) Modeling the cost-effectiveness of colorectal cancer screening: policy guidance based on patient preferences and compliance. CEBP 18(7):1971\u20131978","journal-title":"CEBP"},{"issue":"3","key":"864_CR21","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1111\/j.1572-0241.2005.41829.x","volume":"100","author":"S Agrawal","year":"2005","unstructured":"Agrawal S, Bhupinderjit A, Bhutani MS, Boardman L, Nguyen C, Romero Y et al (2005) Colorectal cancer in African Americans. Am J Gastroenterol 100(3):515\u2013523. (discussion 514)","journal-title":"Am J Gastroenterol"},{"issue":"108","key":"864_CR22","first-page":"e101","volume":"96\u2013108","author":"I Lansdorp-Vogelaar","year":"2009","unstructured":"Lansdorp-Vogelaar I, van Ballegooijen M, Zauber AG, Boer R, Wilschut J, Winawer SJ et al (2009) Individualizing colonoscopy screening by sex and race. Gastrointest Endosc 96\u2013108(108):e101\u2013e124","journal-title":"Gastrointest Endosc"},{"issue":"29","key":"864_CR23","doi-asserted-by":"publisher","first-page":"9759","DOI":"10.3748\/wjg.v20.i29.9759","volume":"20","author":"M Muc-Wierzgon","year":"2014","unstructured":"Muc-Wierzgon M, Nowakowska-Zajdel E, Dziegielewska-Gesiak S, Kokot T, Klakla K, Fatyga E et al (2014) Specific metabolic biomarkers as risk and prognostic factors in colorectal cancer. World J Gastroenterol 20(29):9759\u20139774","journal-title":"World J Gastroenterol"},{"issue":"11 Pt 1","key":"864_CR24","first-page":"2494","volume":"14","author":"SD Ramsey","year":"2005","unstructured":"Ramsey SD, Burke W, Pinsky L, Clarke L, Newcomb P, Khoury MJ (2005) Family history assessment to detect increased risk for colorectal cancer: conceptual considerations and a preliminary economic analysis. CEBP 14(11 Pt 1):2494\u20132500","journal-title":"CEBP"},{"issue":"9","key":"864_CR25","first-page":"1612","volume":"22","author":"RA Hubbard","year":"2013","unstructured":"Hubbard RA, Johnson E, Hsia R, Rutter CM (2013) The cumulative risk of false-positive fecal occult blood test after 10 years of colorectal cancer screening. CEBP 22(9):1612\u20131619","journal-title":"CEBP"},{"key":"864_CR26","unstructured":"Pignone M, Russell L, Wagner J (eds) (2005) Economic models of colorectal cancer screening in average-risk adults: workshop summary. Institute of medicine and national research council, Washington DC, USA"},{"key":"864_CR27","unstructured":"Zauber AG, Lansdorp-Vogelaar I, Wilschut J, Knudsen AB, van Ballegooijen M, Kuntz KM (2007) Cost-effectiveness of DNA stool testing to screen for Colorectal cancer. AHRQ Technology Assessment, Rockville, Maryland, USA"},{"issue":"7","key":"864_CR28","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1111\/j.1572-0241.2000.02172.x","volume":"95","author":"RM Ness","year":"2000","unstructured":"Ness RM, Holmes AM, Klein R, Dittus R (2000) Cost-utility of one-time colonoscopic screening for colorectal cancer at various ages. AJG 95(7):1800\u20131811","journal-title":"AJG"},{"issue":"8","key":"864_CR29","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1200\/JCO.2013.50.9257","volume":"32","author":"KH Lu","year":"2014","unstructured":"Lu KH, Wood ME, Daniels M, Burke C, Ford J, Kauff ND et al (2014) American society of clinical oncology expert statement: collection and use of a cancer family history for oncology providers. JCO 32(8):833\u2013840","journal-title":"JCO"},{"issue":"2","key":"864_CR30","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s10897-011-9462-x","volume":"21","author":"BD Riley","year":"2012","unstructured":"Riley BD, Culver JO, Skrzynia C, Senter LA, Peters JA, Costalas JW et al (2012) Essential elements of genetic cancer risk assessment, counseling, and testing: updated recommendations of the National Society of Genetic Counselors. J Genet Couns 21(2):151\u2013161","journal-title":"J Genet Couns"},{"issue":"5","key":"864_CR31","doi-asserted-by":"publisher","first-page":"331","DOI":"10.3949\/ccjm.79a.11065","volume":"79","author":"M Doerr","year":"2012","unstructured":"Doerr M, Teng K (2012) Family history: still relevant in the genomics era. Cleve Clin J Med 79(5):331\u2013336","journal-title":"Cleve Clin J Med"},{"issue":"9","key":"864_CR32","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1097\/MLR.0b013e3180ca9ac5","volume":"45","author":"PF Stalmeier","year":"2007","unstructured":"Stalmeier PF, Lamers LM, Busschbach JJ, Krabbe PF (2007) On the assessment of preferences for health and duration: maximal endurable time and better than dead preferences. Med Care 45(9):835\u2013841","journal-title":"Med Care"},{"issue":"15","key":"864_CR33","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1001\/jama.2012.13088","volume":"308","author":"L Moreira","year":"2012","unstructured":"Moreira L, Balaguer F, Lindor N, de la Chapelle A, Hampel H, Aaltonen LA et al (2012) Identification of Lynch syndrome among patients with colorectal cancer. JAMA 308(15):1555\u20131565","journal-title":"JAMA"},{"key":"864_CR34","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1146\/annurev-genom-082509-141811","volume":"11","author":"R Cook-Deegan","year":"2010","unstructured":"Cook-Deegan R, Heaney C (2010) Patents in genomics and human genetics. Annu Rev Genomics Hum Genet 11:383\u2013425","journal-title":"Annu Rev Genomics Hum Genet"},{"issue":"2","key":"864_CR35","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1097\/GIM.0b013e3181cd666c","volume":"12","author":"M Mvundura","year":"2010","unstructured":"Mvundura M, Grosse SD, Hampel H, Palomaki GE (2010) The cost-effectiveness of genetic testing strategies for Lynch syndrome among newly diagnosed patients with colorectal cancer. Genet Med 12(2):93\u2013104","journal-title":"Genet Med"}],"container-title":["Cancer Causes & Control"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-017-0864-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10552-017-0864-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-017-0864-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T20:12:03Z","timestamp":1589659923000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10552-017-0864-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,21]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["864"],"URL":"https:\/\/doi.org\/10.1007\/s10552-017-0864-4","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"value":"0957-5243","type":"print"},{"value":"1573-7225","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,21]]},"assertion":[{"value":"7 October 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have no conflict of interest or financial disclosures to report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}